tiprankstipranks
Medicamen Biotech Limited (IN:MEDICAMEQ)
:MEDICAMEQ
India Market
MEDICAMEQ
Medicamen Biotech Limited
RESEARCH TOOLSreports

Medicamen Biotech Limited (MEDICAMEQ) Ratios

0 Followers

Medicamen Biotech Limited Ratios

IN:MEDICAMEQ's free cash flow for Q2 2026 was ₹0.28. For the 2026 fiscal year, IN:MEDICAMEQ's free cash flow was decreased by ₹ and operating cash flow was ₹0.08. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 2.61 2.11 1.89 1.98 1.69
Quick Ratio
 1.81 1.31 1.19 1.43 1.32
Cash Ratio
 0.51 0.05 0.17 0.25 0.05
Solvency Ratio
 0.17 0.17 0.21 0.26 0.26
Operating Cash Flow Ratio
 -0.14 -0.13 -0.08 -0.08 0.06
Short-Term Operating Cash Flow Coverage
 -0.35 -0.33 -0.23 -0.25 0.20
Net Current Asset Value
₹ 1.32B₹ 804.45M₹ 720.27M₹ 782.60M₹ 438.14M
Leverage Ratios
Debt-to-Assets Ratio
 0.11 0.11 0.11 0.09 0.11
Debt-to-Equity Ratio
 0.14 0.16 0.15 0.13 0.18
Debt-to-Capital Ratio
 0.12 0.14 0.13 0.12 0.15
Long-Term Debt-to-Capital Ratio
 0.01 0.02 <0.01 <0.01 0.03
Financial Leverage Ratio
 1.33 1.40 1.42 1.44 1.54
Debt Service Coverage Ratio
 0.42 0.51 0.61 0.90 1.00
Interest Coverage Ratio
 1.75 2.15 11.75 5.38 9.64
Debt to Market Cap
 0.12 0.05 0.06 0.03 0.03
Interest Debt Per Share
 31.27 28.66 28.05 23.36 22.70
Net Debt to EBITDA
 -0.27 1.47 0.66 0.18 0.85
Profitability Margins
Gross Profit Margin
32.17%23.99%47.52%48.82%41.57%
EBIT Margin
7.58%8.02%9.74%12.52%15.50%
EBITDA Margin
11.16%12.37%13.70%19.67%22.35%
Operating Profit Margin
3.94%4.18%28.82%12.95%16.20%
Pretax Profit Margin
5.65%6.08%7.29%12.10%15.67%
Net Profit Margin
5.65%4.37%6.10%10.54%12.90%
Continuous Operations Profit Margin
4.33%4.03%5.29%10.46%12.90%
Net Income Per EBT
100.09%71.95%83.60%87.09%82.33%
EBT Per EBIT
143.22%145.46%25.30%93.42%96.73%
Return on Assets (ROA)
2.57%2.39%3.71%5.33%6.60%
Return on Equity (ROE)
4.11%3.34%5.28%7.67%10.17%
Return on Capital Employed (ROCE)
2.34%3.11%24.61%9.31%12.23%
Return on Invested Capital (ROIC)
1.59%1.82%15.65%7.14%8.87%
Return on Tangible Assets
2.57%2.40%3.72%5.35%6.61%
Earnings Yield
2.88%1.13%2.17%1.81%1.90%
Efficiency Ratios
Receivables Turnover
 2.15 2.36 3.24 2.16 1.83
Payables Turnover
 2.62 2.90 2.81 1.52 1.72
Inventory Turnover
 1.64 1.99 1.58 1.60 2.50
Fixed Asset Turnover
 1.96 1.89 1.97 1.54 1.25
Asset Turnover
 0.45 0.55 0.61 0.51 0.51
Working Capital Turnover Ratio
 2.42 2.01 2.30 2.15 2.48
Cash Conversion Cycle
 252.37 212.44 213.02 156.29 133.33
Days of Sales Outstanding
 169.81 154.71 112.49 169.09 199.89
Days of Inventory Outstanding
 221.92 183.56 230.30 228.12 146.14
Days of Payables Outstanding
 139.36 125.83 129.77 240.92 212.71
Operating Cycle
 391.73 338.27 342.78 397.21 346.04
Cash Flow Ratios
Operating Cash Flow Per Share
 -9.15 -7.76 -5.33 -5.05 3.36
Free Cash Flow Per Share
 -10.75 -9.39 -10.29 -10.35 -3.68
CapEx Per Share
 1.60 1.63 4.97 5.30 7.05
Free Cash Flow to Operating Cash Flow
 1.18 1.21 1.93 2.05 -1.09
Dividend Paid and CapEx Coverage Ratio
 -5.70 -2.95 -0.89 -0.80 0.42
Capital Expenditure Coverage Ratio
 -5.70 -4.76 -1.07 -0.95 0.48
Operating Cash Flow Coverage Ratio
 -0.32 -0.30 -0.22 -0.24 0.16
Operating Cash Flow to Sales Ratio
 -0.07 -0.06 -0.04 -0.04 0.04
Free Cash Flow Yield
-4.46%-1.90%-2.58%-1.57%-0.57%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 34.68 88.21 46.17 55.29 52.55
Price-to-Sales (P/S) Ratio
 1.96 3.86 2.81 5.83 6.78
Price-to-Book (P/B) Ratio
 1.19 2.95 2.44 4.24 5.35
Price-to-Free Cash Flow (P/FCF) Ratio
 -22.41 -52.55 -38.73 -63.65 -174.01
Price-to-Operating Cash Flow Ratio
 -26.34 -63.60 -74.84 -130.42 190.53
Price-to-Earnings Growth (PEG) Ratio
 -3.49 -2.50 -1.75 -14.65 2.31
Price-to-Fair Value
 1.19 2.95 2.44 4.24 5.35
Enterprise Value Multiple
 17.29 32.66 21.21 29.79 31.19
Enterprise Value
 3.22B 6.57B 5.21B 8.26B 8.05B
EV to EBITDA
 17.29 32.66 21.21 29.79 31.19
EV to Sales
 1.93 4.04 2.91 5.86 6.97
EV to Free Cash Flow
 -22.06 -55.02 -39.99 -64.03 -178.89
EV to Operating Cash Flow
 -25.93 -66.59 -77.26 -131.21 195.88
Tangible Book Value Per Share
 202.58 166.90 162.79 154.56 119.60
Shareholders’ Equity Per Share
 203.06 167.49 163.50 155.28 119.89
Tax and Other Ratios
Effective Tax Rate
 0.23 0.34 0.27 0.14 0.18
Revenue Per Share
 122.94 127.95 141.64 113.09 94.50
Net Income Per Share
 6.95 5.60 8.63 11.92 12.19
Tax Burden
 1.00 0.72 0.84 0.87 0.82
Interest Burden
 0.74 0.76 0.75 0.97 1.01
Research & Development to Revenue
 0.00 0.00 0.00 0.01 <0.01
SG&A to Revenue
 0.12 0.20 0.04 0.03 0.04
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 -1.06 -1.39 -0.62 -0.42 0.28
Currency in INR